Clade I, the culprit in the current 2025 version of global epidemic mpox, is highly transmissible and is spreading within ...
Tonix Pharmaceuticals (NASDAQ: TNXP) , a biopharmaceutical company developing innovative vaccines, is advancing TNX-801, a live, minimally replicatin ...